ITC Rules in Favor of ZMC in Coq10 Litigation
date:Dec 06, 2012
The U.S. International Trade Commission (ITC) has issued a notice terminating the patent infringement investigation brought by Kaneka Corporation with a finding of no violation by Zhejiang Medicine Co., Ltd. (ZMC).

The ITC instituted an investigation on July 19, 2011, based on a complaint filed by Kaneka on June 17, 2011 under Section 337 of the Tariff Act of 1930. Kanekas complaint alleged that ZMCs process for making coenzyme Q10 infringes Kanekas patent, U.S. Patent No. 7,910,340 (the 340 p
1/3 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/26 00:18